Stromal-dependent Tumor Promotion by MIF Family Members

Overview

Journal Cell Signal

Date 2014 Oct 4

PMID 25277536

Citations 12

Authors

Robert A Mitchell

Kavitha Yaddanapudi

Affiliations

Soon will be listed here.

Abstract

Solid tumors are composed of a heterogeneous population of cells that interact with each other and with soluble and insoluble factors that, when combined, strongly influence the relative proliferation, differentiation, motility, matrix remodeling, metabolism and microvessel density of malignant lesions. One family of soluble factors that is becoming increasingly associated with pro-tumoral phenotypes within tumor microenvironments is that of the migration inhibitory factor family which includes its namesake, MIF, and its only known family member, D-dopachrome tautomerase (D-DT). This review seeks to highlight our current understanding of the relative contributions of a variety of immune and non-immune tumor stromal cell populations and, within those contexts, will summarize the literature associated with MIF and/or D-DT.

Citing Articles

Single cell and bulk transcriptome analysis identified oxidative stress response-related features of Hepatocellular Carcinoma.

Zhang S, Li X, Zheng Y, Liu J, Hu H, Zhang S Front Cell Dev Biol. 2023; 11:1191074.

PMID: 37842089 PMC: 10568628. DOI: 10.3389/fcell.2023.1191074.

Chronic inflammation, cancer development and immunotherapy.

Wen Y, Zhu Y, Zhang C, Yang X, Gao Y, Li M Front Pharmacol. 2022; 13:1040163.

PMID: 36313280 PMC: 9614255. DOI: 10.3389/fphar.2022.1040163.

TA-MSCs, TA-MSCs-EVs, MIF: their crosstalk in immunosuppressive tumor microenvironment.

Zhang Z, Zhou X, Guo J, Zhang F, Qian Y, Wang G J Transl Med. 2022; 20(1):320.

PMID: 35842634 PMC: 9287873. DOI: 10.1186/s12967-022-03528-y.

Exosomal MIF Derived From Nasopharyngeal Carcinoma Promotes Metastasis by Repressing Ferroptosis of Macrophages.

Chen W, Zuo F, Zhang K, Xia T, Lei W, Zhang Z Front Cell Dev Biol. 2022; 9:791187.

PMID: 35036405 PMC: 8758577. DOI: 10.3389/fcell.2021.791187.

Macrophage migration inhibitory factor (MIF) inhibitor 4-IPP downregulates stemness phenotype and mesenchymal trans-differentiation after irradiation in glioblastoma multiforme.

Lee S, Kwon H, Park S, Kim C, Ryu H, Kim S PLoS One. 2021; 16(9):e0257375.

PMID: 34516577 PMC: 8437287. DOI: 10.1371/journal.pone.0257375.

References

Sivori S, Pende D, Bottino C, Marcenaro E, Pessino A, Biassoni R . NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells. Eur J Immunol. 1999; 29(5):1656-66. DOI: 10.1002/(SICI)1521-4141(199905)29:05<1656::AID-IMMU1656>3.0.CO;2-1. View

de Palma M, Mazzieri R, Politi L, Pucci F, Zonari E, Sitia G . Tumor-targeted interferon-alpha delivery by Tie2-expressing monocytes inhibits tumor growth and metastasis. Cancer Cell. 2008; 14(4):299-311. DOI: 10.1016/j.ccr.2008.09.004. View

Imai K, Matsuyama S, Miyake S, Suga K, Nakachi K . Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population. Lancet. 2000; 356(9244):1795-9. DOI: 10.1016/S0140-6736(00)03231-1. View

Poschke I, Mougiakakos D, Hansson J, Masucci G, Kiessling R . Immature immunosuppressive CD14+HLA-DR-/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC-sign. Cancer Res. 2010; 70(11):4335-45. DOI: 10.1158/0008-5472.CAN-09-3767. View

Morris K, Nofchissey R, Pinchuk I, Beswick E . Chronic macrophage migration inhibitory factor exposure induces mesenchymal epithelial transition and promotes gastric and colon cancers. PLoS One. 2014; 9(6):e98656. PMC: 4041794. DOI: 10.1371/journal.pone.0098656. View

Koch J, Steinle A, Watzl C, Mandelboim O . Activating natural cytotoxicity receptors of natural killer cells in cancer and infection. Trends Immunol. 2013; 34(4):182-91. DOI: 10.1016/j.it.2013.01.003. View

Mitchell R, Liao H, Chesney J, Fingerle-Rowson G, Baugh J, David J . Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc Natl Acad Sci U S A. 2002; 99(1):345-50. PMC: 117563. DOI: 10.1073/pnas.012511599. View

Covello K, Kehler J, Yu H, Gordan J, Arsham A, Hu C . HIF-2alpha regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth. Genes Dev. 2006; 20(5):557-70. PMC: 1410808. DOI: 10.1101/gad.1399906. View

White E, Strom S, Wys N, Arenberg D . Non-small cell lung cancer cells induce monocytes to increase expression of angiogenic activity. J Immunol. 2001; 166(12):7549-55. DOI: 10.4049/jimmunol.166.12.7549. View

10.

Brandau S, Trellakis S, Bruderek K, Schmaltz D, Steller G, Elian M . Myeloid-derived suppressor cells in the peripheral blood of cancer patients contain a subset of immature neutrophils with impaired migratory properties. J Leukoc Biol. 2010; 89(2):311-7. DOI: 10.1189/jlb.0310162. View

11.

Arens R, Schoenberger S . Plasticity in programming of effector and memory CD8 T-cell formation. Immunol Rev. 2010; 235(1):190-205. PMC: 2937176. DOI: 10.1111/j.0105-2896.2010.00899.x. View

12.

Saccani A, Schioppa T, Porta C, Biswas S, Nebuloni M, Vago L . p50 nuclear factor-kappaB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance. Cancer Res. 2006; 66(23):11432-40. DOI: 10.1158/0008-5472.CAN-06-1867. View

13.

Binsky I, Haran M, Starlets D, Gore Y, Lantner F, Harpaz N . IL-8 secreted in a macrophage migration-inhibitory factor- and CD74-dependent manner regulates B cell chronic lymphocytic leukemia survival. Proc Natl Acad Sci U S A. 2007; 104(33):13408-13. PMC: 1948950. DOI: 10.1073/pnas.0701553104. View

14.

Tarnowski M, Grymula K, Liu R, Tarnowska J, Drukala J, Ratajczak J . Macrophage migration inhibitory factor is secreted by rhabdomyosarcoma cells, modulates tumor metastasis by binding to CXCR4 and CXCR7 receptors and inhibits recruitment of cancer-associated fibroblasts. Mol Cancer Res. 2010; 8(10):1328-43. PMC: 2974061. DOI: 10.1158/1541-7786.MCR-10-0288. View

15.

Sica A, Schioppa T, Mantovani A, Allavena P . Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer. 2006; 42(6):717-27. DOI: 10.1016/j.ejca.2006.01.003. View

16.

Moretta L, Moretta A . Unravelling natural killer cell function: triggering and inhibitory human NK receptors. EMBO J. 2003; 23(2):255-9. PMC: 1271745. DOI: 10.1038/sj.emboj.7600019. View

17.

Girard E, Strathdee C, Trueblood E, Queva C . Macrophage migration inhibitory factor produced by the tumour stroma but not by tumour cells regulates angiogenesis in the B16-F10 melanoma model. Br J Cancer. 2012; 107(9):1498-505. PMC: 3493755. DOI: 10.1038/bjc.2012.392. View

18.

Vuk-Pavlovic S, Bulur P, Lin Y, Qin R, Szumlanski C, Zhao X . Immunosuppressive CD14+HLA-DRlow/- monocytes in prostate cancer. Prostate. 2009; 70(4):443-55. PMC: 2935631. DOI: 10.1002/pros.21078. View

19.

Sica A, Bronte V . Altered macrophage differentiation and immune dysfunction in tumor development. J Clin Invest. 2007; 117(5):1155-66. PMC: 1857267. DOI: 10.1172/JCI31422. View

20.

Qian B, Pollard J . Macrophage diversity enhances tumor progression and metastasis. Cell. 2010; 141(1):39-51. PMC: 4994190. DOI: 10.1016/j.cell.2010.03.014. View